An efficacy of riociguat on oxygenation state during exercise in patients with thromboembolic pulmonary hypertension (CTEPH).

Trial Profile

An efficacy of riociguat on oxygenation state during exercise in patients with thromboembolic pulmonary hypertension (CTEPH).

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2016

At a glance

  • Drugs Riociguat (Primary)
  • Indications Pulmonary hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jun 2016 New trial record
    • 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top